COSMO Pharmaceuticals N.V. (0RGI) Stock Statistics & Valuation Metrics

COSMO Pharmaceuticals N.V. has a market cap or net worth of CHF 966.49M. The enterprise value is CHF 963.95M.

Market Cap

CHF 966.49M

Enterprise Value

CHF 963.95M

COSMO Pharmaceuticals N.V. has 17,543,522 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

17,543,522

Owned by Insiders

―

Owned by Institutions

10.82%

COSMO Pharmaceuticals N.V.’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -1.78%.

Return on Equity (ROE)

-0.01

Return on Assets (ROA)

-0.01

Return on Invested Capital (ROIC)

-1.78%

Return on Capital Employed (ROCE)

-0.02

Revenue Per Employee

322.63K

Profits Per Employee

-11.17K

Employee Count

325

Asset Turnover

0.17

Inventory Turnover

5.38

The current PE Ratio of COSMO Pharmaceuticals N.V. is -166.72. COSMO Pharmaceuticals N.V.’s PEG ratio is 1.63.

PE Ratio

-166.72

PS Ratio

10.60

PB Ratio

1.90

Price to FCF

-45.72

Price to Operating Cash Flow

-53.76

PEG Ratio

1.63

In the last 12 months, COSMO Pharmaceuticals N.V. had revenue of 104.85M and earned -3.63M in profits. Earnings per share was -0.23.

Revenue

104.85M

Gross Profit

48.78M

Operating Income

-10.48M

Pretax Income

-924.00K

Net Income

-3.63M

EBITDA

2.27M

Earnings Per Share (EPS)

-0.23

In the last 12 months, operating cash flow was -20.08M and capital expenditures -3.74M, giving a free cash flow of -23.82M billion.

Operating Cash Flow

-20.08M

Free Cash Flow

-23.82M

Free Cash Flow per Share

-1.40

COSMO Pharmaceuticals N.V. pays an annual dividend of CHF 1.93, resulting in a dividend yield of 3.29%

Dividend Per Share

CHF 1.93

Dividend Yield

3.29%

Payout Ratio

-552.46%

Free Cash Flow Yield

-2.19%

Earnings Yield

-0.59%

Beta

1.27

52-Week Price Change

-9.99%

50-Day Moving Average

54.53

200-Day Moving Average

73.22

Relative Strength Index (RSI)

58.44

Average Volume (3m)

3,036

COSMO Pharmaceuticals N.V. upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).

Last Earnings Date

Jul 23, 2026

Next Earnings Date

Mar 24, 2027

Ex-Dividend Date

Apr 24, 2026

COSMO Pharmaceuticals N.V. as a current ratio of 7.18, with Debt / Equity ratio of 0.88%

Current Ratio

7.18

Quick Ratio

6.77

Debt to Market Cap

0.00

Net Debt to EBITDA

-22.68

Interest Coverage Ratio

-57.54

In the past 12 months, COSMO Pharmaceuticals N.V. has paid 2.59M in taxes.

Income Tax

2.59M

Effective Tax Rate

-2.80

COSMO Pharmaceuticals N.V. EV to EBITDA ratio is -1668.52, with an EV/FCF ratio of -44.61.

EV to Sales

10.35

EV to EBITDA

-1668.52

EV to Free Cash Flow

-44.61

EV to Operating Cash Flow

-52.91

COSMO Pharmaceuticals N.V. has CHF 195.28M in cash and marketable securities with CHF 4.33M in debt, giving a net cash position of CHF 190.96M billion.

Cash & Marketable Securities

CHF 195.28M

Total Debt

CHF 4.33M

Net Cash

CHF 190.96M

Net Cash Per Share

CHF 10.88

Tangible Book Value Per Share

CHF 13.30

Gross margin is 45.52%, with operating margin of -13.37%, and net profit margin of -6.18%.

Gross Margin

45.52%

Operating Margin

-13.37%

Pretax Margin

-3.92%

Net Profit Margin

-6.18%

EBITDA Margin

-0.62%

EBIT Margin

-13.37%

The average price target for COSMO Pharmaceuticals N.V. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-44.72%

EPS Growth Forecast

-110.73%